Safety and immunogenicity of an AS01-adjuvanted varicella zoster virus subunit candidate vaccine (HZ/su)

@inproceedings{Lal2013SafetyAI,
  title={Safety and immunogenicity of an AS01-adjuvanted varicella zoster virus subunit candidate vaccine (HZ/su)},
  author={Himal Lal and Toufik Zahaf and Thomas C. Heineman},
  booktitle={Human vaccines & immunotherapeutics},
  year={2013}
}
An adjuvanted recombinant subunit candidate vaccine (HZ/su) containing varicella zoster virus envelope glycoprotein E was developed for the prevention of herpes zoster and its complications. This study evaluated safety and reactogenicity of HZ/su in an ethnic Japanese population. This was a phase I, open-label and single-center study conducted between March… CONTINUE READING